ERBB2 and neoplasm: A hallmark of the HER2 amplified tumor group was micropapillary growth, which was present in 10 out of 13 cases (77 %): three tumors (23 %) were purely (100 %), one tumor (8 %) extensively (80 %), and six tumors (46 %) focally (up to 10 %) micropapillary.